Search Results 521-530 of 17151 for monoclonal antibody

1. First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects with Acute Myelogenous Leukemia and Selected B-cell Cancers - Mayo Clinic

   Participation eligibility · Must be at least 4 weeks (for FL) or 2 weeks (for DLBCL) since prior cytotoxic, biologic, monoclonal antibody, or investigational ...

2. A Study to Evaluate Pembrolizumab Combined with Intensive Chemotherapy to Treat Patients with Acute Myeloid Leukemia - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

3. Brain Tumor Surgery Clinical Trials - Mayo Clinic Research

   Dinutuximab is a monoclonal antibody that binds to a molecule called GD2, which is found in greater than normal amounts on some types of cancer cells. This ...

4. As stomach cancer rates rise in younger people, knowing symptoms and family history is key

   In late 2024, the FDA also approved the use of a new monoclonal antibody drug that uses a lab-made protein that binds to a specific target on a cancer cell to ...

5. Clinical trials - Oncology (Medical)

   Monoclonal antibodies, such as rituximab, may block cancer growth in different ways by targeting certain cells. Romidepsin and lenalidomide may stop the ...

6. Post-traumatic headache: Clinical trial seeks predictors and therapies

   ... monoclonal antibody. That randomization will occur when a participant has experienced post-traumatic headache for 35 to 56 days. Dr. Schwedt notes that ...

7. Publications - Sadia Z. Shah, M.D. - Mayo Clinic

   ... Monoclonal Antibody Screening Score. Mayo Clin Proc Innov Qual Outcomes. 2023 Apr; 7 (2):109-121 Epub 2023 Jan 11. View PubMed; Shah SZ, Alvarez FG, Sanghavi ...

8. Mayo Clinic COVID-19 vaccination plan for children

   Vaccination should be delayed by 90 days for their children who received monoclonal antibody or convalescent plasma or were given the diagnosis of COVID-19 — ...

9. Mayo Clinic's 2021 achievements affirm 'Bold. Forward.' strategic vision, staff dedication

   ... monoclonal antibody infusions. "The pandemic has brought unprecedented challenges," says Christina Zorn, Mayo Clinic's chief administrative officer ...

10. Clinical trials - Oncology (Medical)

    Monoclonal antibodies, such as obinutuzumab, may interfere with the ability of cancer cells to grow and spread. It is not yet known whether giving ...